Last reviewed · How we verify
NCT03016247: TRUST
TRUST Study of Adolescent Weight Self-Management
NA trial testing TRUST Intervention in Adolescent Obesity in 2 participants. Completed in 31 July 2019.
24 June 2019
Quick facts
| Lead sponsor | University Hospitals Cleveland Medical Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 2 |
| Start date | 15 January 2018 |
| Primary completion | 24 June 2019 |
| Estimated completion | 31 July 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- TRUST Intervention
- Enhanced Usual Care
Conditions studied
- Adolescent Obesity — all drugs for Adolescent Obesity →
Sponsor
University Hospitals Cleveland Medical Center
Who can join
Adults 10 to 12, any sex, with Adolescent Obesity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this pilot study is to evaluate the effect of the Trust-building weight Self-management Together (TRUST) intervention on weight self-management behaviors and neural processing in overweight/obese adolescents. Study aims include comparing the effects of the TRUST intervention with Enhanced Usual Care on BMI and quality of life in overweight/obese early adolescents and exploring differences in neural processing (DMT/TPN switching and reward activation).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03016247
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Adolescent Obesity
Currently open trials in the same condition.
- NCT06616454 — The Effect of Time-Restricted Feeding on Body Composition and Some Metabolic Parameters in Obese Adolescents · NA · recruiting
- NCT06575738 — Physiologic Response to Bariatric Surgery and the Impact of Adjunct Semaglutide in Adolescents · Phase 1 · recruiting
- NCT05935826 — Effect of Amino Acids on Hepatic Fat Content in Adolescents (AMINOS Study) · Phase 3 · recruiting
- NCT06745570 — Improving Sleep, Decision-Making, and Eating in Adolescents with Obesity · NA · active not recruiting
- NCT06208345 — Early Life Intervention in Pediatrics Supported by E-health · NA · recruiting
Other University Hospitals Cleveland Medical Center trials
Trials by the same sponsor.
- NCT06997198 — Deutetrabenazine Treatment for Tardive Dyskinesia in Intellectual/Developmental Disabilities · Phase 4 · not yet recruiting
- NCT07379814 — Rectus Abdominis Detrusor Myoplasty for Urinary Retention · not yet recruiting
- NCT07499648 — Baby Steps to Care · NA · not yet recruiting
- NCT07497737 — OMT for Adhesive Capsulitis · Phase 4 · not yet recruiting
- NCT06523166 — Direct Comparison of Cardiac CT With TEE to Evaluate Watchman FLX LAA Occluder Device Characteristics · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03016247 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospitals Cleveland Medical Center
- Last refreshed: 2 December 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03016247.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing